More than 50 millon Americans suffer from autoimmune diseases. The mis- The association sponsors these programs to
address a severe lack of ed-
diagnosis of these diseases is a major factor in the deaths attributed to mis-
diag
nosis and the
tremendous health care costs assoc-
iated with the diag-
nosis and treatment of
autoimmune dis-
eases.
ucational information, public awareness, and research
into over 80 diseases in this group:
American Autoimmune
Related Diseases
Association, Inc.
The AARDA sponsors physician conferences and symposia in order to encourage collaboration in research and cross fertilization of treatment approaches, scientific knowledge, and pharmaceutical advancements. The association also sponsors public seminars for patients and their families.
A national public awareness campaign is a leading priority as a major focus of this organization because a lack of public information regarding autoimmune diseases is a significant factor in the death rate which can often be attributed to misdiagnosis or delayed diagnosis. It is also a significant factor in high health care costs to individuals and companies alike.
The association funds basic research into autoimmunity as the underlying factor in the majority of serious chronic illnesses. At the present, there is no collaborative approach to autoimmune research. The focus of most research has been directed to specific diseases rather than into autoimmunity.
The association supports a nationwide 800 telephone referral line which provides information, support, and referral services to thousands of inquirers annually.
The association supports a nationwide 800 telephone referral line which provides information, support, and referral services to thousands of inquirers annually.
The association publishes a comprehensive national newsletter quarterly. This informative newsletter is mailed to a nationwide mailing list of interested persons. Some recent sample articles from InFocus Newsletter are on this website. To view these articles, click on articles below.
Press Releases | Advocacy Issues | Q & A | Online Quiz | E-Mail ]